THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS - Maughan, T; Adams, R; Smith, C; Seymour, M; Wilson, R; Meade, A; Fisher, D; Madi, A; Cheadle, J; Kaplan, R (2010)